Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123032773 | 12303277 | 3 | F | 2008 | 20160606 | 20160426 | 20160830 | PER | US-JNJFOC-20160402320 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123032773 | 12303277 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 6 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 20272 | .5 | MG | TABLETS | BID | ||||||
123032773 | 12303277 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | SOLUTION | |||||||||
123032773 | 12303277 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 0 | SOLUTION | |||||||||
123032773 | 12303277 | 9 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | 20588 | SOLUTION | |||||||||
123032773 | 12303277 | 10 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
123032773 | 12303277 | 11 | C | BENZTROPINE | BENZTROPINE | 1 | Unknown | 0 | 1 | MG | UNSPECIFIED | ||||||||
123032773 | 12303277 | 12 | C | FOCALIN | DEXMETHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | 5MG, 10MG, 15MG, 20MG | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123032773 | 12303277 | 1 | Abnormal behaviour |
123032773 | 12303277 | 2 | Abnormal behaviour |
123032773 | 12303277 | 3 | Affective disorder |
123032773 | 12303277 | 4 | Affective disorder |
123032773 | 12303277 | 5 | Attention deficit/hyperactivity disorder |
123032773 | 12303277 | 6 | Attention deficit/hyperactivity disorder |
123032773 | 12303277 | 7 | Abnormal behaviour |
123032773 | 12303277 | 8 | Affective disorder |
123032773 | 12303277 | 9 | Attention deficit/hyperactivity disorder |
123032773 | 12303277 | 10 | Product used for unknown indication |
123032773 | 12303277 | 11 | Product used for unknown indication |
123032773 | 12303277 | 12 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123032773 | 12303277 | Emotional disorder | |
123032773 | 12303277 | Eye movement disorder | |
123032773 | 12303277 | Gynaecomastia | |
123032773 | 12303277 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123032773 | 12303277 | 1 | 200805 | 200809 | 0 | |
123032773 | 12303277 | 2 | 200909 | 0 | ||
123032773 | 12303277 | 3 | 200805 | 200809 | 0 | |
123032773 | 12303277 | 4 | 200909 | 0 | ||
123032773 | 12303277 | 5 | 200909 | 0 | ||
123032773 | 12303277 | 6 | 200805 | 200809 | 0 | |
123032773 | 12303277 | 7 | 200503 | 200610 | 0 | |
123032773 | 12303277 | 8 | 200503 | 200610 | 0 | |
123032773 | 12303277 | 9 | 200503 | 200610 | 0 | |
123032773 | 12303277 | 11 | 2007 | 2009 | 0 | |
123032773 | 12303277 | 12 | 2006 | 2009 | 0 |